RDDT scores 70/100 with 69% revenue growth. TGT yields 3.7% at 15x forward earnings. How ACCE's open picks stack up right now.
Open Picks Scorecard: RDDT, TGT, LULU, GXO, IQV Reviewed
With ten open picks on the board as of June 11, 2026, this is a good moment to take stock of what the data actually shows. Not every thesis has played out on the same timeline. Some names have seen meaningful news since publication. Others are still waiting on a catalyst. Here is a frank look at where five of the most data-rich open picks stand today.
Reddit (RDDT): The Growth Case Remains Intact
Reddit Inc. (RDDT) was picked on a simple premise: a platform growing revenue at 30%-plus per year, with 90% gross margins, was being punished for a competitive-fear headline that had nothing to do with its underlying business.
The current data makes that case look stronger, not weaker. Year-over-year revenue growth has accelerated to 69.1%. Earnings growth came in at 675.0% year over year. The trailing P/E sits at 50.7x, which sounds stretched until you look at the forward multiple of 39.2x and realize the earnings base is expanding fast. Market cap stands at $34.29B against a consensus analyst target of $224.92.
The stock is down 30% year-to-date, which is exactly the setup the original thesis described. The ACCE score of 70/100 is the highest among the five names reviewed here. Nothing in the fundamentals justifies the drawdown. The competitive-fear narrative has not materialized in the revenue line.
Target (TGT): Turnaround Data Points Are Accumulating
Target Corporation (TGT) was picked after CEO Brian Cornell's successor Brian Fiddelke delivered the company's first post-earnings guidance raise in two years. The thesis was straightforward: a consumer-defensive franchise with a 3.7% dividend yield and a forward P/E of 15.0x was being priced like a structurally impaired retailer.
Year-over-year revenue grew 6.7%. The trailing P/E is 16.7x. Market cap is $57.51B. Analyst consensus sits at $131.66.
The earnings picture is more complicated. Year-over-year earnings fell 24.7%, which is the number bears will cite. But the guidance raise is the more forward-looking signal, and the dividend at 3.7% provides real income while the turnaround plays out. At 15.0x forward earnings with a yield that rivals many fixed-income alternatives, the margin of safety here is tangible.
lululemon (LULU): Cheap on Every Metric, Waiting on the Catalyst
lululemon athletica (LULU) was picked on valuation and governance: under 10x forward earnings for a zero-debt brand with 57% gross margins, two activist investors, and a board vote scheduled for June 25, 2026.
The current data confirms the valuation case. Forward P/E is 9.1x. Trailing P/E is 9.8x. Market cap is $13.78B. Analyst target is $136.34.
The earnings line is the complication. Year-over-year earnings fell 35.0%, and revenue growth of 4.3% is modest for a brand that once compounded at 20%-plus. The bear case is that LULU is a growth stock that has lost its growth, now trading at a value multiple because the market has correctly repriced it.
The bull case is that the June 25 board vote is a near-term catalyst that could accelerate management changes, and that 9.1x forward earnings for a brand with this margin profile and zero debt is pricing in a worst-case scenario that is unlikely to materialize. The next two weeks will tell a lot.
GXO Logistics (GXO): The Beat Is In, the Re-Rating Has Not Happened
GXO Logistics Inc. (GXO) was picked as a contract logistics leader trading 24% below its 52-week high despite a 35% Q1 EPS beat and raised guidance. The core argument was that the market was ignoring a fundamental improvement in the business.
Year-over-year revenue grew 10.8%. Market cap is $5.78B. Analyst consensus is $70.67, which implies meaningful upside from current levels. Forward P/E is 16.3x.
The trailing P/E of 44.9x looks alarming, but the forward multiple tells the real story: earnings are expected to expand sharply. Year-over-year earnings fell 55.5% on a trailing basis, which explains the gap between the two multiples and also explains why the stock has not re-rated yet. The market is waiting for the earnings recovery to show up in reported numbers, not just guidance. The 35% Q1 beat suggests that process is underway. The ACCE score of 43/100 reflects the trailing earnings drag, not the forward trajectory.
IQVIA (IQV): The Cheapest Large-Cap Healthcare Name on the Board
IQVIA Holdings (IQV) was picked as the largest pure-play contract research organization and healthcare data business in the world, trading at roughly 14x forward earnings, a significant discount to the medical-research peer median.
The data holds up. Forward P/E is 14.6x. Trailing P/E is 22.8x. Year-over-year revenue grew 8.4% and earnings grew 15.0%. Market cap is $30.60B. Analyst target is $228.10. ACCE score is 59/100.
IQV is the most straightforward compounder in the open picks list. Revenue is growing, earnings are growing faster than revenue, and the stock trades at a discount to peers. There is no governance drama, no turnaround risk, no binary catalyst. The thesis is simply that a high-quality business at a below-market multiple should close that gap over time.
What the Scorecard Shows
Across these five names, a few patterns emerge:
- RDDT has the strongest fundamental momentum and the largest gap between current sentiment and underlying business performance.
- TGT and IQV are the most straightforward risk-reward setups: growing businesses at reasonable multiples with clear income or valuation support.
- LULU is the highest-conviction near-term catalyst play, with the June 25 board vote as the pivot point.
- GXO requires patience. The earnings recovery is in motion but has not yet shown up in trailing figures, which is keeping the score and the stock price suppressed.
The broader open picks list also includes APi Group Corporation (APG), Flowserve Corporation (FLS), Evolv Technologies (EVLV), RENK Group (R3NK.DE), Hexagon AB (HEXA-B.ST), and S&P Global (SPGI). Each carries its own catalyst timeline and risk profile.
The next major inflection point across the board is the LULU governance vote on June 25. After that, Q2 earnings season will begin repricing several of these names based on whether the forward estimates embedded in their multiples are actually achievable.
